Morgan Stanley Scopus Bio Pharma Inc. Transaction History

Morgan Stanley

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.23 - $0.45 $0 - $0	2 New	2 $0
Q2 2022 Aug 15, 2022	SELL	$0.36 - $0.74 $759 - $1,560	-2,109 Closed	0 $0
Q1 2022 Oct 27, 2022	BUY	$0.6 - $1.7 $1,265 - $3,585	2,109 New	2,109 $1,000
Q1 2022 May 13, 2022	SELL	$0.6 - $1.7 $25,141 - $71,235	-41,903 Reduced 95.21%	2,109 $1,000
Q4 2021 Feb 14, 2022	BUY	$1.63 - $4.28 $70,109 - $184,091	43,012 Added 4301.2%	44,012 $72,000
Q3 2021 Nov 15, 2021	BUY	$4.0 - $6.99 $4,000 - $6,990	1,000 New	1,000 $4,000

Ticker SCPS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,094,300
Description
Scopus BioPharma Inc., a clinical-stage biopharmaceutical company, focuses on developing transformational therapeutics targeting serious diseases. The company lead development programs are immuno-oncology gene therapy for the treatment of various cancers. It offers Duet Platform, a CpG signal transducer and activator of transcription 3 (STAT3) i...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.